Select Page

South Delhi Pharma, New Delhi, India

Crizalk (Crizotinib) Tablets

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

Facts of Crizalk 250mg / Xalkori 250mg

Brand Name: Crizalk (Crizotinib)
Generic Name: Crizotinib
Form: Tablets
Strength: 250mg
Manufactured By: Pfizer
Packing: 60 tablets pack

South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Crizalk (Crizotinib)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Crizalk (Crizotinib) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

What Crizalk is?

Crizalk is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. This indication is based on response rate.

What Crizotinib is?

Crizotinib has an aminopyridine structure, and functions as a protein kinase inhibitor by competitive binding within the ATP-binding pocket of target kinases. About 4% of patients with non-small cell lung carcinoma have a chromosomal rearrangement that generates a fusion gene between EML4 ('echinoderm microtubule-associated protein-like 4') and ALK ('anaplastic lymphoma kinase'), which results in constitutive kinase activity that contributes to carcinogenesis and seems to drive the malignant phenotype. The kinase activity of the fusion protein is inhibited by crizotinib.

 

Reviews

There are no reviews yet.

Be the first to review “Crizalk (Crizotinib) Tablets”

Your email address will not be published.